We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


CRISPR Engineered Cells Enable Variant Disease Modeling

CRISPR Engineered Cells Enable Variant Disease Modeling content piece image

Comprehensive disease modeling can be challenging for many labs due to variations in reagents, cell culture conditions, technical inconsistencies across protocols and experiments and bandwidth limitations. These limitations make it challenging to model the heterogeneity in clinical phenotypes and the underlying genotypes in genetic diseases.

Download this app note to discover how a cell engineering platform can: 

  • Deliver robust CRISPR engineered cells
  • Enable scientists to achieve desired genotypes and high-quality cell models at an affordable cost
  • Leverage automated and highly standardized processes for consistent editing